Melodi
Disaster Cat
I'm posting this because the amazing results were in human trials, not on rats or something; on the other hand note the swipe at Brexit the "journalist" could not resist (aka the UK will now have to wait in line for larger markets). I also have to wonder just what the price tag on this will be especially in the US - a million dollars a treatment wouldn't surprise me...Melodi
'Extraordinary' new cancer drug appears to cure a third of terminal lymphoma patients in small study
Experts say results are promising but caution further research is needed to establish if the cancer will return; the side-effects may also include a small risk of death
A private drug company has developed an experimental cancer drug that has produced apparently “extraordinary” results, with a third of very ill lymphoma patients showing no signs of the disease after a single treatment.
However the company, Kite Pharma, cautioned that its version of CAT-T cell therapy may have also killed two of the 101 people in the study.
The patients had non-Hodgkin lymphoma and all other treatments had failed. Normally they could expect to live for about six months.
Read more
Nearly nine months later, more than a third showed no sign of the disease and more than half were still alive.
The treatment uses gene therapy to prompt the patient’s blood cells to attack cancer. In total 82 per cent of patients saw their tumours shrink by half or more at some point in the study.
One patient, Dimas Padilla, 43, of Orlando, credited the treatment with saving his life.
He had been told his cancer was getting worse and his treatment was failing. “I was thinking how am I going to tell this to my mother, my wife, my children,” he said.
Read more
Mother shares painful image of 10-year-old son’s fight with cancer
But in August, he had CAR-T therapy and subsequently saw his tumours “shrink like ice cubes”. He is now in complete remission.
“They were able to save my life,” Mr Padilla said.
And independent expert, Dr Roy Herbst, cancer medicines chief at the Yale Cancer Centre, was taken aback by the treatment’s success.
“This seems extraordinary … extremely encouraging,” he said.
However Dr Herbst said further studies were needed to see if the benefit of the treatment was lasting or if the patients’ cancer returned.
“This certainly is something I would want to have available [to patients],” he said.
Martin Ledwick, Cancer Research UK’s head cancer information nurse, also expressed caution.
“These results are promising and suggest that one day CAR-T cells could become a treatment option for some patients with certain types of lymphoma,” he said.
“But, we need to know more about the side effects of the treatment and long-term benefits.”
http://www.independent.co.uk/life-s...therapy-kite-pharma-non-hodgkin-a7613346.html
'Extraordinary' new cancer drug appears to cure a third of terminal lymphoma patients in small study
Experts say results are promising but caution further research is needed to establish if the cancer will return; the side-effects may also include a small risk of death
A private drug company has developed an experimental cancer drug that has produced apparently “extraordinary” results, with a third of very ill lymphoma patients showing no signs of the disease after a single treatment.
However the company, Kite Pharma, cautioned that its version of CAT-T cell therapy may have also killed two of the 101 people in the study.
The patients had non-Hodgkin lymphoma and all other treatments had failed. Normally they could expect to live for about six months.
Read more
Nearly nine months later, more than a third showed no sign of the disease and more than half were still alive.
The treatment uses gene therapy to prompt the patient’s blood cells to attack cancer. In total 82 per cent of patients saw their tumours shrink by half or more at some point in the study.
One patient, Dimas Padilla, 43, of Orlando, credited the treatment with saving his life.
He had been told his cancer was getting worse and his treatment was failing. “I was thinking how am I going to tell this to my mother, my wife, my children,” he said.
Read more
Mother shares painful image of 10-year-old son’s fight with cancer
But in August, he had CAR-T therapy and subsequently saw his tumours “shrink like ice cubes”. He is now in complete remission.
“They were able to save my life,” Mr Padilla said.
And independent expert, Dr Roy Herbst, cancer medicines chief at the Yale Cancer Centre, was taken aback by the treatment’s success.
“This seems extraordinary … extremely encouraging,” he said.
However Dr Herbst said further studies were needed to see if the benefit of the treatment was lasting or if the patients’ cancer returned.
“This certainly is something I would want to have available [to patients],” he said.
Martin Ledwick, Cancer Research UK’s head cancer information nurse, also expressed caution.
“These results are promising and suggest that one day CAR-T cells could become a treatment option for some patients with certain types of lymphoma,” he said.
“But, we need to know more about the side effects of the treatment and long-term benefits.”
http://www.independent.co.uk/life-s...therapy-kite-pharma-non-hodgkin-a7613346.html
